Net2Drug was an international research project, funded by the EU and coordinated by Dr. Alexander Kel at BIOBASE. It aimed at developing a set of tools that combines different experimental high-throughput methods together with bio- and chemoinformatical approaches.

The contribution of my department at UMG was (1) to provide an all-genome prediction of potential transcription factor binding sites (TFBSs) based on statistical scoring plus conservativity analysis across multiple genomes, and (2) to provide an integrated regulatory & metabolic network and optimal filters when mapping experimental gene expression data on such a network.

This project ended by 31st of July, 2010. The final project meeting was held in Alghero, Sardinia, on July 21st/22nd, 2010.

You may learn more about the UMG contribution to Net2Drug here or about the consortium at the central Net2Drug web pages.